To explore the pathophysiology of post-exertional malaise (PEM). Investigate the changes occurring in cardiovascular parameters, cognitive capacity, physical capacities, brain activation and perfusion, and metabolites in patients with ME/CFS…
ID
Source
Brief title
Condition
- Other condition
Synonym
Health condition
Myalgic encephalomyelitis, chronic fatigue syndrome
Research involving
Sponsors and support
Intervention
Outcome measures
Primary outcome
Cardiovascular measures:
- Values obtained during T1 and T2 during prone and standing conditions of
Heart rate (HR), Blood pressure (BP), Oxy- and deoxygenated hemoglobine
concentration (oxy-Hb, deoxy-Hb)
Neuromuscular measures
- Absolute values and changes over time during T1 and T2 of maximal index
finger abduction force, voluntary activation of the index finger abductor
- Absolute values and changes over time during T3, and T4 of maximal index
finger abduction force
Cognitive measures:
- Absolute values and changes over time during T1 and T2 of reaction times and
percentage of correct responses
-Absolute values and changes over time during T3 and T4 of reaction times and
percentage of correct responses
MRI measures during T3 and T4:
-BOLD activation at rest and during a cognitive and physical tasks.
-Arterial spin labelling (ASL) at rest and during physical task.
Secondary outcome
- Changes over time, during physical and cognitive task performance of heart
rate, blood pressure, oxygen and deoxygenated hemoglobin concentration
- Metabolites
- Patient-reported outcome measures (PEM questionnaires, Chalder fatigue scale,
SSS questionnaire, EQ-5D questionnaire, DPEMQ, SF-36, HADS, Bell_CFDIS scale,
COMPASS-31, PSQI, MFIS
- Scores of daily activity and sleep patterns:
o time spent at different activity intensities and sedentary time.
o sleep parameters such as time in bed, sleep time, waking up after sleep
onset, waking time.
o Heart rate variability (HRV) measured during cognitive and physical tasks in
the lab and for 7 days during daily activities
- Number of repetitions in the two 30 chair to stand tests (30CST)
- Handgrip strength
- Knee extensor force
Neuromuscular measures
- Absolute values and changes over time during T1 vs T2 and T3 vs T4 of the
index finger abductor force decline (fatigability) during sustained contraction
Background summary
Exercise is an important contributor to general health and is considered a
potential remedy for chronic diseases. This is in strong contrast with the
observation that in most ME/CFS patients exercise aggravates their symptoms.
Recently, post-exertional malaise (PEM) is defined as the key symptom of
ME/CFS. The etiology and pathophysiological mechanisms underlying ME/CFS are
still unknown and objective diagnostic criteria are not available. Various
hypotheses are postulated including disorders of several organ systems but the
heterogenous presentation of symptoms in patients, and the multisystem deficits
complicate reaching an all-encompassing hypothesis. It seems therefore
reasonable to focus on the key symptom, i.e., PEM. PEM can be induced by minor
cognitive or physical exertion and can be assessed with questionnaires. Acute
physical activity triggers complex cardiovascular, metabolic, and molecular
responses and for ME/CFS, it is important to understand the relation between
these acute processes and the prolonged presentation of aggravated symptoms. We
therefore want to measure metabolites, cardiovascular responses, cognitive
performance, muscle force and fatigability in 50 controls matched on group
level for sex, age, and activity. To follow changes in these parameters over we
perform time-series analysis, before, during and after recovery of task
performance. Besides understanding these interactions, it is also essential to
understand how these acute and prolonged responses affect behaviour and
perception. To obtain objective and subjective measures of perception we
include advanced brain activation analysis (measures of brain activity and
network analysis), together with effort and PEM-related questionnaires.
Study objective
To explore the pathophysiology of post-exertional malaise (PEM). Investigate
the changes occurring in cardiovascular parameters, cognitive capacity,
physical capacities, brain activation and perfusion, and metabolites in
patients with ME/CFS compared with sex, age, and activity matched controls
before and after physical and cognitive fatiguing tasks on two consecutive
days. Secondary objectives are to investigate the differences in sleep
patterns, activity levels and heart rate variability in ME/CFS patients and
their matched controls as well as to find associations between patient report
outcomes and changes in the response of organ systems.
Study design
A single centre, cross-sectional, experimental study in which effects of
cognitive and physical tasks are followed.
Study burden and risks
Participants will be asked to perform physical and cognitive fatiguing tasks
while measuring cardiovascular parameters as well as brain activation and
perfusion and various blood samples will be taken. Regarding the experimental
protocol it is anticipated that after performing our protocol ME/CFS patients
will perceive a temporary worsening of their symptoms (e.g. fatigue, muscular
and joint pain, headaches, brain fog), but no serious adverse events are
expected. The importance of investigating worsening of symptoms in detail and
on so many different levels, allows us to identify and better understand the
parameters involved in the mechanisms of the disease. Possible additional
burdens that all our participants may experience during our study are the
following:
Collection of 8 blood samples over three days
Determination of voluntary muscle activation with the superimposed twitch
technique may feel a bit painful but for less than one second.
Standardized vascular occlusion test of the thigh muscle can feel uncomfortable
Time investment: 5 times 2.5 hours of measurements as well as the filling in of
the questionnaires at home (90 min* + 4*3 min), total= ca. 14.5 hours.
Hanzeplein 1
Groningen 9700AV
NL
Hanzeplein 1
Groningen 9700AV
NL
Listed location countries
Age
Inclusion criteria
- Age > 18 years but <65.
- Willing and be able to complete all study procedures.
- Able to provide informed consent
Additional inclusion criteria for ME/CFS patients:
- ME/CFS patients must meet international concensus criteria (ICC) or Canadian
consensus criteria (CCC).
- A self-reported illness narrative of the development of persistent fatigue.
- Existence of post-exertional malaise according to the DSQ-2.
- The persistent fatigue may have an acute onset or become progressively worse
over 6 months.
Exclusion criteria
Exclusion criteria for all subjects:
- Use of immune-modulating drugs in the past 3 months.
- A serious medical condition that may explain symptoms similar to ME/CFS, such
as cancer, coronary artery disease, uncontrolled diabetes, chronic infection
(hepatitis B and C, tuberculosis, HIV), inflammatory diseases, autoimmune
diseases (e.g. such as rheumatoid arthritis, lupus or polymyositis), severe
COPD or other severe persistent respiratory disease, severe anaemia, renal
failure, Addison's or Cushing's disease or severe neurological disease (such as
Parkinson's disease).
- History of head injury with loss of consciousness or amnesia lasting greater
than a few seconds within last five years or lasting greater than 5 minutes at
any point during their lifetime.
- Suspected, probable, or confirmed Lyme disease.
- Current or substance use disorder within last 5 years.
- A mood disorder or other psychiatric diagnosis (prior to a diagnosis of
ME/CFS).
- Pregnant, actively seeking to become pregnant or breastfeeding in the past 12
months.
- BMI >35.
- having cognitive or communication problems which reduces the capacity to
understand instructions.
- planned a change in medication during the testing period.
- Use of medication that affects the blood pressure (e.g., Beta-blockers,
fludrocortisone, vasoconstrictors).
- Participation in a clinical protocol (e.g., anti-inflammatory drug
intervention study) which includes an intervention that may affect the results
of the current study.
- Having claustrophobia
- Current (within 1 week) use of prescription or over-the-counter medications,
herbal supplements, or nutraceuticals that may influence brain excitability.
Examples of medications that influence brain excitability include tricyclic
antidepressants, hypnotic, antiepileptic, antipsychotic medication, stimulants,
antihistamines, muscle relaxants, dopaminergic medications, and sleep
medications.
- Use of B12 high dosage injections
- colour blindness
Additional exclusion criteria for control subjects:
- performing high intensity or moderate intensity activities more than 30
minutes per week
- substantial fatigue as determined using MFIS fatigue questionnaire >30 .
Design
Recruitment
Followed up by the following (possibly more current) registration
No registrations found.
Other (possibly less up-to-date) registrations in this register
No registrations found.
In other registers
Register | ID |
---|---|
Other | ClinialTrails.gov |
CCMO | NL85693.042.23 |